Lung Cancer Screening for Smokers: Who Qualifies and New Targeted Therapies
May 6 2026
Clinical Outcomes with Biosimilars: Do They Work as Well as the Original Biologics?
Biosimilars are not cheap copies - they’re rigorously tested alternatives to expensive biologic drugs. Data from hundreds of thousands of patients shows they work just as well, with the same safety and effectiveness. Here’s what the evidence says.
